2013
DOI: 10.1186/ar4356
|View full text |Cite
|
Sign up to set email alerts
|

A new paradigm of quality of care in rheumatoid arthritis: how our new therapeutics have changed the game

Abstract: Demonstrating the effectiveness of expensive new rheumatoid arthritis (RA) therapeutics is imperative to determine whether the quality of care has improved with the introduction of these agents. Our current RA quality measures are primarily process based, but they must become outcomes based to better demonstrate quality. New RA quality measures must be multidimensional, accounting for all of the important outcomes in RA: radiographic, functional status, and disease activity. To fully understand the potential b… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
2
0

Year Published

2015
2015
2016
2016

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 8 publications
(8 reference statements)
0
2
0
Order By: Relevance
“…New studies are thus needed to understand relationships between process-based quality measures and patient outcomes. The results of these studies will guide revisions of current quality measures and the development of new ones, including outcomes-based measures of disease activity and function [ 19 ]. Evolving value-based care delivery models may pose some barriers associated with extra time demands for performing, documenting, and reporting quality measures.…”
Section: Discussionmentioning
confidence: 99%
“…New studies are thus needed to understand relationships between process-based quality measures and patient outcomes. The results of these studies will guide revisions of current quality measures and the development of new ones, including outcomes-based measures of disease activity and function [ 19 ]. Evolving value-based care delivery models may pose some barriers associated with extra time demands for performing, documenting, and reporting quality measures.…”
Section: Discussionmentioning
confidence: 99%
“…The literature has explicitly criticized the model for its lack of patient-centeredness 10 and its failure to cover chronic and palliative care 11 and raised questions of how to define outcomes in chronic care settings, such as the care of rheumatoid arthritis (RA). 12 However, empirical data have not substantiated this criticism, the model itself, or scientific applications of the model.…”
mentioning
confidence: 99%